Julia Valencak

1.3k total citations
38 papers, 939 citations indexed

About

Julia Valencak is a scholar working on Oncology, Pathology and Forensic Medicine and Dermatology. According to data from OpenAlex, Julia Valencak has authored 38 papers receiving a total of 939 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 14 papers in Pathology and Forensic Medicine and 13 papers in Dermatology. Recurrent topics in Julia Valencak's work include Lymphoma Diagnosis and Treatment (13 papers), Cutaneous lymphoproliferative disorders research (11 papers) and Neuroendocrine Tumor Research Advances (6 papers). Julia Valencak is often cited by papers focused on Lymphoma Diagnosis and Treatment (13 papers), Cutaneous lymphoproliferative disorders research (11 papers) and Neuroendocrine Tumor Research Advances (6 papers). Julia Valencak collaborates with scholars based in Austria, Germany and United States. Julia Valencak's co-authors include Markus Raderer, Gabriela Kornek, Werner Scheithauer, Michael Hejna, Andreas Chott, Hubert Pehamberger, D. Depisch, Franz Trautinger, B Dragosics and Friedrich Lang and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Julia Valencak

37 papers receiving 910 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julia Valencak Austria 18 475 332 280 209 169 38 939
Yufan Cheng China 16 385 0.8× 177 0.5× 326 1.2× 210 1.0× 69 0.4× 51 949
Albina Altemani Brazil 22 626 1.3× 180 0.5× 782 2.8× 255 1.2× 74 0.4× 114 1.3k
Mark Messing United States 13 420 0.9× 160 0.5× 225 0.8× 171 0.8× 34 0.2× 31 1.1k
Fredrik Enlund Sweden 18 555 1.2× 164 0.5× 444 1.6× 231 1.1× 341 2.0× 31 1.4k
Srinivas Mandavilli United States 14 289 0.6× 176 0.5× 213 0.8× 220 1.1× 162 1.0× 30 757
Sanghui Park South Korea 18 261 0.5× 225 0.7× 228 0.8× 133 0.6× 33 0.2× 61 801
Andrea P. Subhawong United States 15 396 0.8× 203 0.6× 234 0.8× 390 1.9× 152 0.9× 29 933
Inny Busmanis Singapore 15 185 0.4× 278 0.8× 210 0.8× 75 0.4× 201 1.2× 46 836
Terri Berk Canada 23 658 1.4× 1.1k 3.2× 366 1.3× 387 1.9× 42 0.2× 40 1.5k
Yasumasa Monobe Japan 13 199 0.4× 88 0.3× 294 1.1× 154 0.7× 67 0.4× 75 856

Countries citing papers authored by Julia Valencak

Since Specialization
Citations

This map shows the geographic impact of Julia Valencak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Valencak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Valencak more than expected).

Fields of papers citing papers by Julia Valencak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Valencak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Valencak. The network helps show where Julia Valencak may publish in the future.

Co-authorship network of co-authors of Julia Valencak

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Valencak. A scholar is included among the top collaborators of Julia Valencak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Valencak. Julia Valencak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Porkert, Stefanie & Julia Valencak. (2023). Cutaneous lymphomas—fast facts about an orphan disease—a short review. memo - Magazine of European Medical Oncology. 16(1). 10–16.
2.
Haitel, Andrea, Julia Walochnik, Julia Valencak, et al.. (2022). Comparison of Permethrin-Based Treatment Strategies against Scabies in Infants and Young Children. The Journal of Pediatrics. 245. 184–189. 7 indexed citations
3.
Walochnik, Julia, Franz Karlhofer, Stefan Winkler, et al.. (2021). Human dirofilariosis in Austria: the past, the present, the future. Parasites & Vectors. 14(1). 227–227. 14 indexed citations
4.
Der-Petrossian, Manon, Julia Valencak, Constanze Jonak, et al.. (2010). Dermal infiltrates of cutaneous T‐cell lymphomas with epidermotropism but not other cutaneous lymphomas are abundant with langerin+ dendritic cells. Journal of the European Academy of Dermatology and Venereology. 25(8). 922–927. 19 indexed citations
5.
Valencak, Julia, Franz Trautinger, Markus Raderer, et al.. (2009). Somatostatin receptor scintigraphy in primary cutaneous T‐ and B‐cell lymphomas. Journal of the European Academy of Dermatology and Venereology. 24(1). 13–17. 5 indexed citations
6.
Valencak, Julia, Elisabeth Heere‐Ress, Tatjana Traub‐Weidinger, et al.. (2005). Somatostatin receptor scintigraphy with 111In-DOTA-lanreotide and 111In-DOTA-Tyr3-octreotide in patients with stage IV melanoma: in-vitro and in-vivo results. Melanoma Research. 15(6). 523–529. 10 indexed citations
7.
Valencak, Julia, Susana Ortiz‐Urda, Elisabeth Heere‐Ress, Rainer Kunstfeld, & Wolfgang Base. (2003). Carbamazepine‐induced DRESS syndrome with recurrent fever and exanthema. International Journal of Dermatology. 43(1). 51–54. 17 indexed citations
8.
Valencak, Julia, Franz Trautinger, Wolfgang Fiebiger, & Markus Raderer. (2002). Complete remission of chronic plaque psoriasis and gastric marginal zone B-cell lymphoma of MALT type after treatment with 2-chlorodeoxyadenosine. Annals of Hematology. 81(11). 662–665. 5 indexed citations
9.
Scheithauer, Werner, Gabriela Kornek, Stefan Brugger, et al.. (2002). Randomized Phase II Study of Irinotecan Plus Mitomycin C vs. Oxaliplatin Plus Mitomycin C in Patients with Advanced Fluoropyrimidine/Leucovorin-Pretreated Colorectal Cancer. Cancer Investigation. 20(1). 60–68. 24 indexed citations
10.
Valencak, Julia, Wolfgang Dietrich, Markus Raderer, et al.. (2000). Evidence of Therapeutic Efficacy of CCNU in Recurrent Choroid Plexus Papilloma. Journal of Neuro-Oncology. 49(3). 263–268. 13 indexed citations
11.
Kwasny, W., Gabriela Kornek, K. Haider, et al.. (2000). Treatment of advanced, refractory breast cancer with alternating docetaxel and epirubicin/cyclophosphamide plus human granulocyte colony-stimulating factor. Breast Cancer Research and Treatment. 63(3). 235–241. 3 indexed citations
12.
Scheithauer, Werner, Gabriela Kornek, Markus Raderer, et al.. (1999). Phase II trial of gemcitabine, epirubicin and granulocyte colony-stimulating factor in patients with advanced pancreatic adenocarcinoma. British Journal of Cancer. 80(11). 1797–1802. 39 indexed citations
13.
Raderer, Markus, Michael Hejna, Amir Kurtaran, et al.. (1999). SUCCESSFUL TREATMENT OF AN ADVANCED HEPATOCELLULAR CARCINOMA WITH THE LONG-ACTING SOMATOSTATIN ANALOG LANREOTIDE. The American Journal of Gastroenterology. 94(1). 278–279. 11 indexed citations
14.
Raderer, Markus, Michael Hejna, Julia Valencak, et al.. (1999). Two Consecutive Phase II Studies of 5-Fluorouracil/Leucovorin/Mitomycin C and of Gemcitabine in Patients with Advanced Biliary Cancer. Oncology. 56(3). 177–180. 114 indexed citations
15.
Haider, K., Gabriela Kornek, W. Kwasny, et al.. (1999). Treatment of advanced breast cancer with gemcitabine and vinorelbine plus human granulocyte colony‐stimulating factor. Breast Cancer Research and Treatment. 55(3). 203–211. 39 indexed citations
16.
Raderer, Markus, Gerhard Hamilton, Amir Kurtaran, et al.. (1999). Treatment of advanced pancreatic cancer with the long-acting somatostatin analogue lanreotide: in vitro and in vivo results. British Journal of Cancer. 79(3-4). 535–537. 14 indexed citations
17.
Balogh, Brigitta, et al.. (1999). The nerve of Henle: An anatomic and immunohistochemical study. The Journal Of Hand Surgery. 24(5). 1103–1108. 31 indexed citations
18.
Raderer, Markus, Julia Valencak, Franz Pfeffel, et al.. (1999). Somatostatin Receptor Expression in Primary Gastric Versus Nongastric Extranodal B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue Type. JNCI Journal of the National Cancer Institute. 91(8). 716–718. 14 indexed citations
19.
Hejna, Michael, Gabriela Kornek, Markus Raderer, et al.. (1998). Mitomycin C, Vinorelbine, Carboplatin plus Granulocyte-Macrophage Colony-Stimulating Factor for Treatment of Advanced Non-Small Cell Lung Carcinoma. Oncology. 55(6). 538–542. 4 indexed citations
20.
Raderer, Markus, Julia Valencak, Werner Scheithauer, et al.. (1998). Expression of Human Somatostatin Receptor Subtype 3 in Pancreatic Cancer In Vitro and In Vivo. JNCI Journal of the National Cancer Institute. 90(21). 1666–1668. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yufan Cheng Breakdown of academic impact, for papers by Albina Altemani Breakdown of academic impact, for papers by Mark Messing Breakdown of academic impact, for papers by Fredrik Enlund Breakdown of academic impact, for papers by Srinivas Mandavilli Breakdown of academic impact, for papers by Sanghui Park Breakdown of academic impact, for papers by Andrea P. Subhawong Breakdown of academic impact, for papers by Inny Busmanis Breakdown of academic impact, for papers by Terri Berk Breakdown of academic impact, for papers by Yasumasa Monobe
Rankless by CCL
2026